# Asses the Anti-inflammatory Effects of Short Term Copaxone Therapy on Patients the Acute Decompensated Heart Failure

> **NCT06003972** · PHASE2 · COMPLETED · sponsor: **Hadassah Medical Organization** · enrollment: 14 (actual)

## Conditions studied

- Acute Decompensated Heart Failure
- Cytokine Storm
- Inflammatory Response
- Heart Failure

## Interventions

- **DRUG:** Copaxone
- **DRUG:** guideline directed medical therapy (GDMT)

## Key facts

- **NCT ID:** NCT06003972
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-04
- **Primary completion:** 2023-03-12
- **Final completion:** 2023-03-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06003972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06003972, "Asses the Anti-inflammatory Effects of Short Term Copaxone Therapy on Patients the Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06003972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*